STRATA Skin Sciences, Inc. Stock

Equities

SSKN

US86272A2069

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:30:00 2024-04-26 EDT 5-day change 1st Jan Change
0.5145 USD -2.78% Intraday chart for STRATA Skin Sciences, Inc. -5.60% -6.47%
Sales 2024 * 31.79M 43.45M Sales 2025 * 34.77M 47.53M Capitalization 18.04M 24.66M
Net income 2024 * -7M -9.57M Net income 2025 * -5M -6.83M EV / Sales 2024 * 0.57 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.52 x
P/E ratio 2024 *
-2.45 x
P/E ratio 2025 *
-3.55 x
Employees 99
Yield 2024 *
-
Yield 2025 *
-
Free-Float 61.19%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.78%
1 week-5.60%
Current month+36.11%
1 month+11.85%
3 months-1.08%
6 months-2.74%
Current year-6.47%
More quotes
1 week
0.50
Extreme 0.499
0.59
1 month
0.36
Extreme 0.36
0.59
Current year
0.36
Extreme 0.36
0.65
1 year
0.26
Extreme 0.262
1.14
3 years
0.26
Extreme 0.262
1.95
5 years
0.26
Extreme 0.262
2.92
10 years
0.26
Extreme 0.262
28.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 18-04-09
Director of Finance/CFO 42 21-07-05
Chief Operating Officer - 14-12-31
Members of the board TitleAgeSince
Director/Board Member 64 22-02-13
Chairman 56 18-05-28
Director/Board Member 70 -
More insiders
Date Price Change Volume
24-04-26 0.5145 -2.78% 7,598
24-04-25 0.5292 -5.50% 2,241
24-04-24 0.56 +3.70% 5,631
24-04-23 0.54 +1.89% 7,504
24-04-22 0.53 -2.75% 9,774

Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm

More quotes
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.5145 USD
Average target price
2.3 USD
Spread / Average Target
+347.04%
Consensus